Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
QIM25-222: Evaluating Implementation of Advanced Provider Driven Comprehensive Management Program to Support Patients With Immune-Oncology Toxicity.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 28, 2025
Consensus disease definitions for ophthalmic immune-related adverse events of immune checkpoint inhibitors.
Journal: Journal for immunotherapy of cancer
Published: March 20, 2025
Defining D-irAEs: consensus-based disease definitions for the diagnosis of dermatologic adverse events from immune checkpoint inhibitor therapy.
Journal: Journal for immunotherapy of cancer
Published: February 05, 2024
Showing 1-3 of 3
Last Updated: 09/26/2026